医疗管理心血管疾病的医疗管理
Kyle Steiger1, Ana Fuentes2, Young Erben2
1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
The Surgical clinics of North America
|July 16, 2023
概括
血管外科医生可以通过使用降脂,抗血小板,抗高血压和降糖疗法来优化患者护理. 未来的研究应该专注于戒烟,运动和营养,以全面管理血管健康.
科学领域:
- 心血管医学 心血管医学
- 血管外科 血管外科
背景情况:
- 对接受血管手术的患者来说,对心血管风险因素的有效管理至关重要.
- 优化医疗疗法可以改善手术结果并减少并发症.
研究的目的:
- 为血管外科医生和医疗团队提供关键医学疗法的概述.
- 突出未来研究领域,以优化患者护理.
主要方法:
- 对当前治疗策略的文献综述.
- 对降脂剂,抗血小板剂,抗高血压剂和降糖剂的证据综合.
主要成果:
- 已建立的疗法包括降脂,抗血小板,抗高血压和降糖药物.
- 这些疗法对于治疗血管疾病患者至关重要.
结论:
- 目前的医疗管理策略对于血管外科手术患者至关重要.
- 建议对戒烟,运动和营养进行进一步的研究,以加强患者护理.
相关概念视频
Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Angina IV: Management
11
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Heart Failure V: Medical Management
14
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9


